Metastatic basal cell carcinoma: Rapid symptomatic response to cisplatin and paclitaxel

ANZ Journal of Surgery

Volumn 74, Issue 8, 2004, Pages 704-705

  Jefford, Michael ^a,d   Kiffer, John D ^d   Somers, Gino ^b   Daniel, Fredy J ^c   Davis, Ian D ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b AUSTIN HEALTH   (Australia)

^c Geelong Hospital ^*

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Basal cell neoplasms; Cisplatin; Metastasis; Non small cell lung carcinoma; Paclitaxel; Palliative care

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; ANAMNESIS; BASAL CELL CARCINOMA; BONE SCINTISCANNING; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG ERUPTION; FACIAL NERVE INJURY; HUMAN; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; REVIEW; VESTIBULOCOCHLEAR NERVE DISEASE; WHOLE BODY AUTORADIOGRAPHY;

ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CISPLATIN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; REMISSION INDUCTION; SKIN NEOPLASMS; TIME FACTORS;

EID: 4444381037     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-1433.2004.03130.x     Document Type: Review

References (10)

1. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-95: are primary prevention programs starting to have an effect? Int. J. Cancer 1998; 78: 144-8.
2. Mikhail GR, Nims LP, Kelly AP Jr, Ditmars DM Jr, Eyler WR. Metastatic basal cell carcinoma: review, pathogenesis, and report of two cases. Arch. Dermatol. 1977; 113: 1261-9.
3. Paver K, Poyzer K, Burry N, Deakin M. The incidence of basal cell carcinoma and their metastases in Australia and New Zealand (Letter). Australas. J. Dermatol. 1973; 14: 53.
4. Safai B, Good RA. Basal cell carcinoma with metastasis. Review of literature. Arch. Pathol. Lab. Med. 1977; 101: 327-31.
5. Johnson TM, Tschen J, Ho C, Lowe L, Nelson BR. Unusual basal cell carcinomas. Cutis 1994; 54: 85-92.
6. Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982; 49: 533-7.
7. von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J. Am. Acad. Dermatol. 1984; 10: 1043-60.
8. Pfeiffer P, Hansen O, Rose C. Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature. Eur. J. Cancer 1990; 26: 73-7.
9. Brown CI, Perry AE. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am. J. Dermatopathol. 2000; 22: 123-5.
10. Neijt JP, Engelholm SA, Tuxen MK et al. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. J. Clin. Oncol. 2000; 18: 3084-92.